nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Retinal haemorrhage—Carmustine—malignant glioma	0.0673	0.0673	CcSEcCtD
Verteporfin—Visual acuity reduced—Temozolomide—malignant glioma	0.0356	0.0356	CcSEcCtD
Verteporfin—Myasthenia—Carmustine—malignant glioma	0.0349	0.0349	CcSEcCtD
Verteporfin—Scotoma—Carmustine—malignant glioma	0.0289	0.0289	CcSEcCtD
Verteporfin—Scotoma—Temozolomide—malignant glioma	0.0279	0.0279	CcSEcCtD
Verteporfin—Hyperaesthesia—Temozolomide—malignant glioma	0.027	0.027	CcSEcCtD
Verteporfin—Injection site pain—Carmustine—malignant glioma	0.0269	0.0269	CcSEcCtD
Verteporfin—Extravasation—Carmustine—malignant glioma	0.0251	0.0251	CcSEcCtD
Verteporfin—Hearing impaired—Temozolomide—malignant glioma	0.0223	0.0223	CcSEcCtD
Verteporfin—Injection site reaction—Carmustine—malignant glioma	0.0218	0.0218	CcSEcCtD
Verteporfin—Musculoskeletal pain—Temozolomide—malignant glioma	0.0215	0.0215	CcSEcCtD
Verteporfin—Dry eye—Temozolomide—malignant glioma	0.0196	0.0196	CcSEcCtD
Verteporfin—Diplopia—Carmustine—malignant glioma	0.0159	0.0159	CcSEcCtD
Verteporfin—Diplopia—Temozolomide—malignant glioma	0.0154	0.0154	CcSEcCtD
Verteporfin—Liver function test abnormal—Carmustine—malignant glioma	0.0147	0.0147	CcSEcCtD
Verteporfin—Muscular weakness—Carmustine—malignant glioma	0.014	0.014	CcSEcCtD
Verteporfin—Muscular weakness—Temozolomide—malignant glioma	0.0136	0.0136	CcSEcCtD
Verteporfin—Pneumonia—Carmustine—malignant glioma	0.0123	0.0123	CcSEcCtD
Verteporfin—Photosensitivity reaction—Temozolomide—malignant glioma	0.0121	0.0121	CcSEcCtD
Verteporfin—Pneumonia—Temozolomide—malignant glioma	0.0119	0.0119	CcSEcCtD
Verteporfin—Haemoglobin—Carmustine—malignant glioma	0.0111	0.0111	CcSEcCtD
Verteporfin—Haemorrhage—Carmustine—malignant glioma	0.011	0.011	CcSEcCtD
Verteporfin—Hypoaesthesia—Carmustine—malignant glioma	0.011	0.011	CcSEcCtD
Verteporfin—Haemoglobin—Temozolomide—malignant glioma	0.0107	0.0107	CcSEcCtD
Verteporfin—Haemorrhage—Temozolomide—malignant glioma	0.0106	0.0106	CcSEcCtD
Verteporfin—Visual impairment—Carmustine—malignant glioma	0.0106	0.0106	CcSEcCtD
Verteporfin—Hypoaesthesia—Temozolomide—malignant glioma	0.0106	0.0106	CcSEcCtD
Verteporfin—Pharyngitis—Temozolomide—malignant glioma	0.0106	0.0106	CcSEcCtD
Verteporfin—Eye disorder—Carmustine—malignant glioma	0.0103	0.0103	CcSEcCtD
Verteporfin—Visual impairment—Temozolomide—malignant glioma	0.0103	0.0103	CcSEcCtD
Verteporfin—Flushing—Carmustine—malignant glioma	0.0102	0.0102	CcSEcCtD
Verteporfin—Eye disorder—Temozolomide—malignant glioma	0.00995	0.00995	CcSEcCtD
Verteporfin—Flushing—Temozolomide—malignant glioma	0.00988	0.00988	CcSEcCtD
Verteporfin—Cardiac disorder—Temozolomide—malignant glioma	0.00988	0.00988	CcSEcCtD
Verteporfin—Angiopathy—Temozolomide—malignant glioma	0.00966	0.00966	CcSEcCtD
Verteporfin—Immune system disorder—Temozolomide—malignant glioma	0.00961	0.00961	CcSEcCtD
Verteporfin—Malnutrition—Carmustine—malignant glioma	0.00959	0.00959	CcSEcCtD
Verteporfin—Back pain—Carmustine—malignant glioma	0.00927	0.00927	CcSEcCtD
Verteporfin—Malnutrition—Temozolomide—malignant glioma	0.00927	0.00927	CcSEcCtD
Verteporfin—Vision blurred—Carmustine—malignant glioma	0.00904	0.00904	CcSEcCtD
Verteporfin—Back pain—Temozolomide—malignant glioma	0.00896	0.00896	CcSEcCtD
Verteporfin—Anaemia—Carmustine—malignant glioma	0.00886	0.00886	CcSEcCtD
Verteporfin—Vision blurred—Temozolomide—malignant glioma	0.00873	0.00873	CcSEcCtD
Verteporfin—Ill-defined disorder—Temozolomide—malignant glioma	0.0086	0.0086	CcSEcCtD
Verteporfin—Anaemia—Temozolomide—malignant glioma	0.00856	0.00856	CcSEcCtD
Verteporfin—Malaise—Temozolomide—malignant glioma	0.00836	0.00836	CcSEcCtD
Verteporfin—Vertigo—Temozolomide—malignant glioma	0.00832	0.00832	CcSEcCtD
Verteporfin—Hypertension—Carmustine—malignant glioma	0.00828	0.00828	CcSEcCtD
Verteporfin—Chest pain—Carmustine—malignant glioma	0.00816	0.00816	CcSEcCtD
Verteporfin—Cough—Temozolomide—malignant glioma	0.00809	0.00809	CcSEcCtD
Verteporfin—Hypertension—Temozolomide—malignant glioma	0.008	0.008	CcSEcCtD
Verteporfin—Arthralgia—Temozolomide—malignant glioma	0.00789	0.00789	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00783	0.00783	CcSEcCtD
Verteporfin—Oedema—Carmustine—malignant glioma	0.00783	0.00783	CcSEcCtD
Verteporfin—Discomfort—Temozolomide—malignant glioma	0.00779	0.00779	CcSEcCtD
Verteporfin—Oedema—Temozolomide—malignant glioma	0.00756	0.00756	CcSEcCtD
Verteporfin—Nervous system disorder—Temozolomide—malignant glioma	0.00742	0.00742	CcSEcCtD
Verteporfin—Skin disorder—Temozolomide—malignant glioma	0.00735	0.00735	CcSEcCtD
Verteporfin—Hyperhidrosis—Temozolomide—malignant glioma	0.00731	0.00731	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00713	0.00713	CcSEcCtD
Verteporfin—Dyspnoea—Carmustine—malignant glioma	0.00698	0.00698	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00689	0.00689	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00676	0.00676	CcSEcCtD
Verteporfin—Dyspnoea—Temozolomide—malignant glioma	0.00674	0.00674	CcSEcCtD
Verteporfin—Constipation—Carmustine—malignant glioma	0.00669	0.00669	CcSEcCtD
Verteporfin—Pain—Carmustine—malignant glioma	0.00669	0.00669	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00653	0.00653	CcSEcCtD
Verteporfin—Pain—Temozolomide—malignant glioma	0.00647	0.00647	CcSEcCtD
Verteporfin—Constipation—Temozolomide—malignant glioma	0.00647	0.00647	CcSEcCtD
Verteporfin—Feeling abnormal—Carmustine—malignant glioma	0.00645	0.00645	CcSEcCtD
Verteporfin—Feeling abnormal—Temozolomide—malignant glioma	0.00623	0.00623	CcSEcCtD
Verteporfin—Body temperature increased—Carmustine—malignant glioma	0.00619	0.00619	CcSEcCtD
Verteporfin—Urticaria—Temozolomide—malignant glioma	0.00601	0.00601	CcSEcCtD
Verteporfin—Body temperature increased—Temozolomide—malignant glioma	0.00598	0.00598	CcSEcCtD
Verteporfin—Hypersensitivity—Carmustine—malignant glioma	0.00577	0.00577	CcSEcCtD
Verteporfin—Asthenia—Carmustine—malignant glioma	0.00561	0.00561	CcSEcCtD
Verteporfin—Hypersensitivity—Temozolomide—malignant glioma	0.00557	0.00557	CcSEcCtD
Verteporfin—Asthenia—Temozolomide—malignant glioma	0.00543	0.00543	CcSEcCtD
Verteporfin—Pruritus—Temozolomide—malignant glioma	0.00535	0.00535	CcSEcCtD
Verteporfin—Dizziness—Carmustine—malignant glioma	0.00517	0.00517	CcSEcCtD
Verteporfin—Dizziness—Temozolomide—malignant glioma	0.005	0.005	CcSEcCtD
Verteporfin—Rash—Carmustine—malignant glioma	0.00493	0.00493	CcSEcCtD
Verteporfin—Dermatitis—Carmustine—malignant glioma	0.00493	0.00493	CcSEcCtD
Verteporfin—Headache—Carmustine—malignant glioma	0.0049	0.0049	CcSEcCtD
Verteporfin—Rash—Temozolomide—malignant glioma	0.00477	0.00477	CcSEcCtD
Verteporfin—Dermatitis—Temozolomide—malignant glioma	0.00476	0.00476	CcSEcCtD
Verteporfin—Headache—Temozolomide—malignant glioma	0.00474	0.00474	CcSEcCtD
Verteporfin—Nausea—Carmustine—malignant glioma	0.00465	0.00465	CcSEcCtD
Verteporfin—Nausea—Temozolomide—malignant glioma	0.00449	0.00449	CcSEcCtD
